Serial Number
78425171
Owner
Focus Diagnostics, Inc.Attorney
Tanya D'SouzaFiling Date
May 26, 2004
FOCUS DIAGNOSTICS Trademark
Serial Number: 78425171 • Registration: 3412644
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 10 - Medical Apparatus
Surgical, medical, dental and veterinary apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
May 26, 2004
Registration Date
April 15, 2008
Published for Opposition
October 31, 2006
Goods & Services
Diagnostic reagents and assays for clinical and medical laboratory use; diagnostic kits consisting of diagnostic reagents and assays for clinical and medical laboratory use
Diagnostic reagents and assays for scientific and research testing; diagnostic kits consisting of diagnostic reagents and assays for scientific and research testing
diagnostic testing apparatus for disease indicators in human blood, urine, sputum and tissue for clinical and medical laboratory use; diagnostic testing apparatus for disease indicators in human blood, urine, sputum and tissue for scientific and research testing
[ Medical laboratory services, namely, microbiological, molecular, genetic, immunological, histopathological, hematological, biochemical and chemical testing; testing of human, animal and environmental specimens and isolates of microorganisms; scientific, research and medical clinical testing of human, animal and environmental specimens and isolates of microorganisms; scientific, research and medical clinical testing and consulting services in the fields of pharmaceuticals, biotechnology and healthcare; data warehousing and analysis of laboratory test results; medical services, namely, monitoring services, diagnostic services, and imaging services for all phases of clinical trials; and epidemiological studies for late phase clinical trials and post-marketing surveillance ]